Browse Drug Recalls
19 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 19 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 19 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Oct 31, 2024 | Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 ... | Defective Delivery System: The product does not meet predetermined specifications for Coldflow (a... | Class II | Noven Pharmaceuticals Inc |
| Mar 10, 2023 | Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx ... | Defective Delivery System: Out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| Mar 10, 2023 | Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx... | Defective Delivery System: Out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| Mar 10, 2023 | Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx ... | Defective Delivery System: Out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| Mar 10, 2023 | Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx... | Defective Delivery System: Out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| Nov 16, 2022 | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (... | Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is ... | Class II | Noven Pharmaceuticals Inc |
| Jun 24, 2022 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.... | Defective Delivery System: Customer complaints received for ripping patches and tight release/adh... | Class II | Noven Pharmaceuticals Inc |
| May 6, 2022 | Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.... | Defective Delivery System: customer complaints exceeded respective action limits. | Class II | Noven Pharmaceuticals Inc |
| Jul 30, 2021 | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg ... | Failed Stability Specifications; out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| Jul 30, 2021 | Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg ... | Failed Stability Specifications; out of specification for shear. | Class II | Noven Pharmaceuticals Inc |
| May 20, 2021 | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1... | Defective Delivery System: The number of customer complaints for ripping patches and tight releas... | Class II | Noven Pharmaceuticals Inc |
| May 20, 2021 | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1... | Defective Delivery System: The number of customer complaints for ripping patches and tight releas... | Class II | Noven Pharmaceuticals Inc |
| Apr 16, 2021 | Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box... | Defective Delivery System: Out of specification for release rate testing and shear, an attribute ... | Class II | Noven Pharmaceuticals Inc |
| Apr 16, 2021 | Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, ... | Defective Delivery System: Out of specification for release rate testing and shear, an attribute ... | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Jan 12, 2015 | Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3... | Defective Delivery System: One lot exceeded the mechanical peel specification | Class II | Noven Pharmaceuticals, Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.